spacer
home > pmps > winter 2001 > developments in the biotechnology and pharmaceutical sectors
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Developments in the biotechnology and pharmaceutical sectors

Perhaps you can begin by giving a brief
overview of your company?

Avecia was formed in July 1999, following completion of a US$2.1 billion (£1.3 billion) buyout of the former Zeneca Specialties business from AstraZeneca. The deal was financed by Cinven and Investcorp - two of Europe's leading financial investment firms.

With sales of £700 million in 2000 and earnings of over £150 million, Avecia is one of Europe's leading and most profitable speciality chemical companies.

Avecia businesses are linked by common scientific and technical capabilities and are focused on delivering service to customers across a wide range of industries including health care, agrochemicals, coatings, graphic arts, leather imaging, mining, plastics, biotechnology, inks and automotive. The company has 4,700 employees and operates in the UK, US, Europe and the Far East.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Patricia Lobo, Editor of PMPS
John Blackie is currently the General Manager of Manufacturing for Pharmaceuticals and Biotechnology at Avecia. He is based in Scotland with accountability for manufacturing in Grangemouth in Scotland, Huddersfield in West Yorkshire and Billingham Teeside in north-east England. John graduated in chemical engineering from the University of Edinburgh.

After a few years in plant design and development, he entered manufacturing management. John has held a
variety of posts in site and operations management over 20 years within the ICI, Zeneca and most recently, Avecia groups. He has been a Senior Manager responsible for manufacturing in the UK for nine years and has spent two and a half years running Syngenta's (formerly Zeneca's) Belgian operations.


spacer
Patricia Lobo
spacer
spacer
spacer
John Blackie
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Huge CPhI & P-MEC China a direct result of surging manufacturing

Shanghai, 22 July, 2019:CPhI and P-MEC China – organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, and Shanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market in China continues to grow. The three-day Shanghai event featured 3,200+ exhibiting companies, spanning the entire pharma supply chain, and provides a strong indication of the market’s overall growth patterns and future development.
More info >>

White Papers

Case Study: Getting the Client’s Trust - Oncology Program

Cmed Clinical Services

Five years ago, a biopharmaceutical company chose Cmed to conduct a phase II oncology study. Cmed’s performance of the study and the good relationship established with the Client led Cmed to be awarded a second oncology trial which a couple of years ago was followed by a third, fourth and fifth.
More info >>

 
Industry Events

SAPHEX 2019

23-24 October 2019, GALLAGHER CONVENTION CENTRE, 10 RICHARDS DRIVE, HALFWAY HOUSE, MIDRAND, 1685, SOUTH AFRICA

SAPHEX 2019 will be held on the 23rd-24th October at the Gallagher Convention Centre, Johannesburg, South Africa.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement